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Benign liver lesions in female patients
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Livercelladenomaandfocalnodularhyperplasia
arebenignconditions,oftenencounteredinyoung
andmiddleagedfemalepatients. Theycanpresent
acutely,butmoreoftenarediagnosedincidentally
during investigation of abnormal liver function
tests or vague abdominal pain. We present four
cases, which contrast the diagnosis and
management offocalnodularhyperplasia (FNH)
and liver cell adenoma (LCA).
CASE 1
A 33-year-old previously healthy woman was
admitted with sudden onset ofepigastric and left
upper abdominal pain. Her only regular
medication was the oral contraceptive pill, used
almostcontinuouslyfortheprevioussixteenyears.
Ultrasound and CT scans wereperformed. These
revealed a large mass in the left lobe ofthe liver
into which bleeding had occurred (Fig. 1). In
addition there was a large lesion in the posterior
aspect ofthe right lobe. Appearance on CT scan
was in keeping with a ruptured lesion in the left
lobe and focal nodular hyperplasia in the right
lobe. Laparotomy revealed a large tumour in
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Fig 1. CT scan, from patient 1, demonstrating a large
heterogeneous lesion in the left lobe, into which
bleeding has occurred (curved arrow).
segmentsIIandIIIwithsomesurroundingsatellite
nodules. There was evidence of haemorrhage
into the tumour and ahaematoma, was present in
the left upper quadrant. Left hepatic lobectomy
was performed. Histopathology confirmed the
left lobe lesion to be a liver adenoma; biopsy of
the right lobe lesion revealed focal nodular
hyperplasia. She remains well three years
following surgery. Repeat CT scan at two years
has demonstrated no change in size of the right
lobe lesion.
CASE 2
A26-year-oldwomanwithathreeyearhistory of
oral contraceptive use presented with a three-
month history of right-sided abdominal pain.
Clinical examination was unremarkable butUSS
oftheabdomenshoweda5x7x8cmhyperechoic
mass in the right lobe of the liver. Contrast
enhanced CT scan demonstrated the same lesion
and the presence of a central scar. On repeat CT
imaging six months later no significant change
was seen. This is consistent with a diagnosis of
focalnodularhyperplasia. Eighteen months after
initial presentation she remains well.
CASE 3
A 29-year-old woman was admitted electively
forlaparoscopic cholecystectomy. During initial
laparoscopyatumourarisingfromtheleftlobeof
the liver was noted. Conversion to open
cholecystectomy allowed routine cholecystec-
tomy and biopsy of the liver lesion to be
performed. Histopathology was consistent with
focalnodularhyperplasia. AnenhancedCTscan,
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onemonthaftersurgery,revealednofocalhepatic
abnormality. Inthesucceedingmonths,thepatient
experiencedepisodesofepigastricpain.Afurther
CT scan six months after surgery identified a
3.8 cm diameter lesion in the left lobe with no
central scar or internal haemorrhage. A third CT
scan eighteen months after her initial surgery
showed no change. However the patient was
experiencing intermittent episodes ofabdominal
pain. This fact, combined with herdesire to have
a further child in the future, resulted in elective
surgerytoenucleatetheFNHlesionfromsegment
IV of the liver.
CASE 4
A54-year-oldwomanwasnotedtohaveabnormal
liver function tests on routine investigation of
abdominal pain. Her only past medical history
was essential hypertension, treated with thiazide
diuretics. She had lived in Australia and had
travelled to the Far East, but had no known
history of hepatitis. Ultrasound revealed a 6 x
4 cmmassintheposterioraspectoftherightlobe
of the liver. This was irregular in outline, and
mainly echogenic but with an echo-poor centre.
CT scan showed a well-defined mass measuring
5 x 6 x 5 cm, which was hypodense with acentral
stellate scar (Fig.2). The appearances were
consistent with FNH. CT guided biopsy was
performed. Thehistologyrevealedunremarkable
hepatic architecture, and the biopsy was not
diagnostic of FNH from the material submitted.
Repeat CT scan 8 months after the initial
investigations showednosignificantchange.The
patient has remained well two years later.
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Fig 2. CT scan, from patient 4, demonstrating a
hypodense mass in the right lobe, with a central
stellate scar (curved arrow).
DISCUSSION
Theassociationbetweenthedevelopmentofliver
cell adenoma (LCA) and the use of oral
contraceptives was first reported in 1973.1Early
reportsestimatedthattheriskofdevelopingLCA
increases thirty four fold in women using high
oestrogen oral contraceptives.2 Recent studies
for low dose oestrogen contraceptives showed
the riskto be increased onlyby afactorofthree.3
Prolonged duration of oral contraceptive use
increases the risk of liver cell adenoma. One
studydemonstratedthatuseoforalcontraceptives
forfive, nine orgreaterthan nine years increases
the risk by 2, 5, 7.5 and 25 respectively.4 In
contrast, focal nodular hyperplasia (FNH),
although more common than LCA, is not
associatedwiththeuseoforalcontraceptives and
the increased incidence in the past twenty five
years is likely to be due to increased awareness
and the more widespread use of ultrasound.5
The natural history of these conditions varies.
LCA carries a significant risk of complications
such as rupture, haemoperitoneum, shock, death
and, rarely, malignant transformation.6 FNH
however is essentially benign. It is not
premalignant andcomplications such as massive
growth, rupture or haemorrhage are rare.5 In the
few reported cases with haemorrhage the
histological diagnosis of FNH has been
questioned.6This fundamental difference inlong
term behaviour influences the presentation and
management of the two conditions.
Case 1 is typical of LCA. Eighty percent of
patientswithhepatic adenomaaresymptomatic-
halfofthese have signs related to a mass, such as
pain, whilst the other half are symptomatic
because of haemorrhage. This may be
intratumoural, subcapsular or intraperitoneal.
Essentially thereverse is true inFNH. Typically,
only 10%ofthisgrouphavesymptoms,thelesion
being found incidentally in the remaining 90%,
as in cases 3 and4.7 In one case series, nopatient
withFNHhadpresentedwithruptureorbleeding.8
Radiological imaging alone is not always
diagnostic, but nonetheless can help in
differentiating FNH from LCA. The presence of
an avascular central stellate scar, although not
alwaysfound, ispathognomonicforFNHwhenit
occurs, sinceitneverarisesinlivercelladenoma.7
Similarly, precontrast hyperdense areas
(haemorrhage) is supportive of the diagnosis of
LCA. Differentiation can also be made with less
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widely available imaging techniques. These
include MRI with or without gadolinium
enhancement, colour doppler ultrasound and
radionuclide scintigraphy, with Technetium
(Tc 99) sulphur colloid.
With MRI the central stellate area of FNH is
hyperintenseonT2andhypointenseonT1 images.
Enhancement with gadolinium shows
accumulation ofcontrastagentwithinthecentral
area on delayed Ti images. For LCA,
haemorrhageishyperintenseonT1 andT2images,
while necrosis is hyperintense on T2 and
hypointense on Ti images. Characteristically
LCA shows no accumulation of gadolinium
contrast agent within the tumour.9
With colour doppler FNH shows arterial signals
within the tumour, while LCA demonstrates
venous signals. Using radio labelled colloid a
focaldefectisseeninLCA,comparedtoincreased
or normal uptake in FNH.9 This stems from the
histolgicaldifferenceoftheselesions. LCAlacks
Kupffer cells, and does not take up radioisotope.
In FNH Kupffer cells are present and
metabolically active resulting in increased
uptake.7
Histologically these lesions differ.10
Macroscopically, LCAis yellowish tanin colour
withahomogeneous appearance. Thereisnotrue
capsule but a pseudocapsule may be created by
the compression of normal liver parenchyma.
Haemorrhage,bothmacroscopicandmicroscopic,
is common. Macroscopically, lobulation and a
central scar are characteristic of FNH.
Microscopically Kupffer cells and bile ducts are
found in FNH, but are absent in LCA, which is
distinguished by the presence of glycogen rich
vacuoles. However, differentiation and definite
diagnosisonpercutaneousbiopsyisoftendifficult
as the tumour, particularly FNH, can so closely
resemble normal liver parenchyma. Case 4
illustrates this point well, as the radiological
diagnosisofFNHwasnotconclusivelysupported
by percutaneous biopsy. Percutaneous biopsy is
considered safe, but complications including
haemorrhage and death do occur. However
mortality rates following the procedure are
extremely low (0.03-0.006%).11 Imaging and
histology, along with the clinical history may all
be used to make the diagnosis of LCA or FNH.
This is important because, the natural history of
the two conditions differs markedly and so,
therefore, does their management.
Discontinuation of oral contraceptives is
obligatory in patients with LCA. Although
occasionally regression has been observed after
discontinuationthisisnotinvariable, andgrowth,
rupture and malignant transformation have been
reported, despite cessation of contraceptive
use.7 12Mostauthorsagreethatoralcontraceptives
are not the causal agent ofFNH. However, ithas
been postulated that they might have a trophic
effect increasing the size and vascularity.
Therefore,discontinuationoforalcontraceptives
is also advised in this condition.
The management of FNH requires a flexible
approach.Asymptomaticlesionsarebestmanaged
expectantly and can be safely observed with
regularultrasound. Theonlyclearindications for
surgery are the presence of symptoms or
uncertainty aboutthediagnosis. Inthelattercase,
if resection is a major hazard biopsy alone is
recommended since the prognosis of FNH left
undisturbed is excellent. For symptomatic FNH,
resection has been demonstrated to be safe with
nooperativemortalityandlessthan 1%morbidity.
Reliefofsymptoms is also generally achieved."3
A further indication for resection of FNH is
planned pregnancy, if the tumour is easily
accessible. This is because it has been well
documented that these lesions may increase in
size during pregnancy.14 It is for these reasons
that patient 3 underwent elective surgery. The
diagnosis of LCA strongly supports surgical
intervention,duetolongtermrisksofconservative
management.ElectiveresectionofLCAisalmost
as safe as FNH, morbidity and mortality for this
being 7% and less than 1% respectively. This
increases to 5-8% for emergency resection.5
In summary, FNH and LCA are liver masses
identified in women and the latter is clearly
increased by use of oral contraceptive steroids.
They differ in histological and radiological
characteristicsandtheseareoftenofuseinmaking
a diagnosis. While FNH is often asymptomatic
and benign, LCA is, by contrast, often
symptomatic with a potential for significant
complications. TheserisksinherentinLCAmake
surgical intervention in this condition the
treatment of choice.
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